| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $78,831,460 ) (Continued on the next page) |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K01AI173385 | Leveraging within-host M. tuberculosis diversity data to enhance transmission inference | 000 | 3 | NIH | 11/19/2024 | $132,057 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA247994 | Mitochondrial lateral transfer during metastasis | 003 | 5 | NIH | 4/25/2025 | $0 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U24HL147018 | 2/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED) | 000 | 5 | NIH | 11/26/2024 | $505,281 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA247994 | Mitochondrial lateral transfer during metastasis | 001 | 5 | NIH | 3/21/2025 | $313,959 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM148283 | Symbiosis and Chemical Diversity Generation | 001 | 3 | NIH | 1/16/2025 | $486,266 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23DK132487 | The Serine Protease HTRA1 Antigen: A Gateway to Elucidating Membranous Nephropathy Pathogenesis and the Targeting of Antigen Epitopes | 000 | 3 | NIH | 4/1/2025 | $174,960 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33TW011636 | Rwanda 912: an mHealth Application to Improve Quality of Trauma and Emergency Care in Kigali, Rwanda | 000 | 5 | NIH | 4/12/2025 | $253,338 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL170007 | Cardiovascular and neuromuscular issues in chronic pain | 000 | 2 | NIH | 4/24/2025 | $686,302 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA282219 | Multilevel RCT of Rural Community Sun Safety for Young Children in Sports | 000 | 2 | NIH | 4/7/2025 | $509,398 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA290182 | Mechanical Stress and Lung Tumor Progression | 000 | 2 | NIH | 4/16/2025 | $461,181 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA240612 | Biology and Targeting of noncoding RNAs in AML | 000 | 5 | NIH | 3/13/2025 | $317,048 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA289731 | The combined role of ARID1A loss and estrogen signaling in endometrial cancer | 000 | 2 | NIH | 3/4/2025 | $380,042 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD099487 | Comorbid Disease in Women with Primary Ovarian Insufficiency | 000 | 6 | NIH | 2/1/2025 | $558,419 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK139317 | Discovery and design of novel insulin evologs from venomous marine cone snails | 000 | 2 | NIH | 2/25/2025 | $351,923 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI185994 | Elucidating influenza-induced protection of malaria-associated respiratory distress syndrome in mice | 000 | 1 | NIH | 2/24/2025 | $224,070 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH104603 | Deciphering gene-environment interactions in pathological reactive aggression | 000 | 9 | NIH | 3/4/2025 | $626,434 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00EY032119 | Bridging gap in comparative biology using the tree shrew visual system | 000 | 5 | NIH | 2/14/2025 | $249,000 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 002 | 11 | NIH | 4/9/2025 | $46,751 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 002 | 11 | NIH | 4/9/2025 | $226,156 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 001 | 11 | NIH | 3/12/2025 | $420,761 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 001 | 11 | NIH | 3/12/2025 | $2,035,408 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK135968 | Beta-cell self-antigen recognition by diabetogenic CD8 T cells | 000 | 3 | NIH | 2/21/2025 | $346,500 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI172210 | Biophysical parameters of self-reactive TCR engagement in T1D | 000 | 3 | NIH | 2/13/2025 | $646,169 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG1HD087226 | NICHD Cooperative Multicenter Neonatal Research Network - Utah Center | 002 | 10 | NIH | 4/3/2025 | $339,184 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD107077 | Economic security policy and birth outcomes among socio-economically disadvantaged women | 001 | 3 | NIH | 4/24/2025 | $32,178 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD107077 | Economic security policy and birth outcomes among socio-economically disadvantaged women | 000 | 3 | NIH | 3/3/2025 | $289,596 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA267990 | Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine | 000 | 4 | NIH | 1/28/2025 | $324,186 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA263505 | SOX2 acts in the 3D genome of squamous cancer | 000 | 2 | NIH | 12/19/2024 | $367,201 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA264971 | Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s | 000 | 4 | NIH | 1/28/2025 | $503,493 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21HL172288 | Overcoming explainability and data availability barriers to broad application of ECG ML screening with a system-wide ECG dataset | 000 | 2 | NIH | 12/13/2024 | $115,500 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL167866 | Pathobiological mechanisms of cardiac disease in PGM1-CDG | 000 | 2 | NIH | 11/14/2024 | $586,682 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG1CA233178 | Huntsman Cancer Institute/ University of Utah Network Lead Academic Participating Site Application | 002 | 6 | NIH | 3/10/2025 | $301,967 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AR081006 | Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial | 000 | 3 | NIH | 11/8/2024 | $152,460 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK139541 | Structural Mechanisms of Polycystic Kidney Disease Proteins | 000 | 2 | NIH | 4/15/2025 | $666,838 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY035158 | Regulation of Retinal Neurogenesis by Foxp1 | 000 | 2 | NIH | 11/21/2024 | $578,854 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM150766 | Integrated mass spectrometry-based chemoproteomic and genomic technologies for studying dynamic kinase interactomes | 000 | 3 | NIH | 4/11/2025 | $385,000 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI162929 | Targeting OCA-B in multiple sclerosis | 000 | 4 | NIH | 1/9/2025 | $399,740 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY028927 | Retinal Circuitry | 000 | 6 | NIH | 3/13/2025 | $685,322 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K01AG065623 | Developing and Testing the Enhancing Active Caregiver Training (EnACT) Intervention for Dementia Family Caregivers | 000 | 5 | NIH | 1/23/2025 | $132,570 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG080440 | Area-level Socio-economic Conditions and Individual-level Health and Mortality: Exploring Place-Based Mechanisms and Individual-level Psychosocial Processes | 000 | 3 | NIH | 12/23/2024 | $489,143 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21EB035378 | A gaze-controlled neck exoskeleton for dropped head syndrome | 000 | 2 | NIH | 12/26/2024 | $165,280 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA121118 | A High-Throughput Model for Human Melanoma | 000 | 15 | NIH | 11/7/2024 | $260,775 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 000 | 8 | NIH | 3/7/2025 | $346,500 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR082973 | Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility | 000 | 2 | NIH | 3/7/2025 | $525,081 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08CA252883 | Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia | 000 | 4 | NIH | 3/13/2025 | $289,908 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T35DK103596 | MSRP in Metabolism, Diabetes, Digestive and Kidney Diseases | 000 | 10 | NIH | 3/3/2025 | $44,200 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH132822 | Prefrontal Circuit Control of Isolation-Induced Aggression | 000 | 3 | NIH | 2/13/2025 | $486,185 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23HL157751 | A theory-based practice guide for creating patient education | 000 | 4 | NIH | 2/20/2025 | $149,623 |
| 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA271740 | Investigating the regulation and mechanism of tension-sensors Stu2 & Ndc80c | 001 | 3 | NIH | 5/12/2025 | -$28,247 |
|